Vaxcyte, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $183.2M | $260.8M | $174.0M | $281.1M | $306.7M | $346.9M | $387.9M | $1.05B |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $1.55B | $1.81B | $1.63B | $1.77B | $1.72B | $1.72B | $1.79B | $2.21B |
| Property, Plant & Equipment | $260.4M | $260.7M | $257.4M | $253.5M | $242.3M | $217.2M | $198.0M | $163.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $3.14B | $3.35B | $3.00B | $3.17B | $3.31B | $3.38B | $3.51B | $3.56B |
| Liabilities | ||||||||
| Accounts Payable | $100.9M | $63.1M | $70.9M | $49.0M | $31.4M | $20.5M | $48.5M | $18.2M |
| Total Current Liabilities | $271.3M | $242.1M | $205.8M | $200.0M | $154.5M | $97.0M | $140.2M | $123.8M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $380.2M | $352.3M | $317.2M | $278.7M | $234.0M | $178.1M | $205.5M | $142.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-2.76B | $-2.48B | $-2.15B | $-1.91B | $-1.70B | $-1.53B | $-1.39B | $-1.25B |
| Total Stockholders' Equity | $2.76B | $3.00B | $2.69B | $2.89B | $3.07B | $3.20B | $3.31B | $3.42B |